Medtronic Vascular
medtronic.comTotal trials
60
Active
10
Phase 3
1
Total enrollment
53,928
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Coronary Artery Disease34
- Cardiovascular Diseases19
- Hypertension14
- Vascular Diseases10
- Ischemic Heart Disease9
- Arteriosclerosis8
- Stenotic Coronary Lesion5
- Uncontrolled Hypertension4
Frequently asked questions about Medtronic Vascular
- How many clinical trials does Medtronic Vascular have on ClinicalTrials.gov?
- Medtronic Vascular is listed as the lead sponsor on 60 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medtronic Vascular's trials are in Phase 3?
- 1 of Medtronic Vascular's trials are in Phase 3.
- What therapeutic areas does Medtronic Vascular focus on?
- Medtronic Vascular's most-studied conditions on ClinicalTrials.gov are Coronary Artery Disease, Cardiovascular Diseases, Hypertension, Vascular Diseases, Ischemic Heart Disease.